等待开盘 10-13 09:30:00 美东时间
+0.320
+0.83%
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
今日重点评级关注:Truist Securities:维持Inventiva"买入"评级,目标价从13美元升至18美元;富瑞:维持Sagimet Biosciences"买入"评级,目标价从25美元升至26美元
10-05 16:26
Piper Sandler analyst Stephen Scouten maintains Servisfirst Bancshares (NYSE:SFBS) with a Overweight and lowers the price target from $47 to $46.
10-02 22:13
ServisFirst Bancshares, Inc. will announce its Q3 2026 earnings on October 19, 2026, at 4 p.m. ET, with a live webcast at 5:15 p.m. ET. The company, based in Birmingham, Alabama, provides financial services across multiple states. More details and filings are available on its website or via contact at (205) 949-3420.
09-29 22:10
ServisFirst (SFBS) declares $0.19/share quarterly dividend. vs. prior dividend of $0.38. To note, the company completed a 2-for-1 stock split in 2026, so the current $0.19 quarterly dividend is on a p...
09-22 12:26
ServisFirst Bancshares, Inc. (NYSE: SFBS) announced on September 21, 2026, that its Board of Directors declared a quarterly cash dividend of $0.19 per share, payable on October 9, 2026, to stockholders of record as of October 1, 2026. The company, based in Birmingham, Alabama, operates through its subsidiary ServisFirst Bank, providing financial services across multiple states including Alabama, Florida, Georgia, and others.
09-21 22:23
ServisFirst Bank, a subsidiary of ServisFirst Bancshares, ranked sixth among top-performing U.S. banks with $10 billion to $50 billion in assets, according to American Banker's annual list. The ranking, by Capital Performance Group, is based on a three-year average return on average equity (ROAE) using 2025 data. ServisFirst Bancshares reported a three-year average ROAE of 15.39% and a 2025 net interest margin of 3.12%. The bank's strong performa...
08-24 19:29
ServisFirst Bancshares ( ($SFBS) ) has shared an update. ServisFirst Bancshares...
08-08 05:48
今日重点评级关注:HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从50美元升至69美元;高盛:维持Taysha Gene Therapies"买入"评级,目标价从11美元升至13美元
07-22 11:35
Piper Sandler analyst Stephen Scouten maintains Servisfirst Bancshares (NYSE:SFBS) with a Overweight and raises the price target from $91 to $94.
07-22 01:48